Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Express Scripts
Mallinckrodt
Baxter
Colorcon

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Litigation Details for AstraZeneca Pharmaceuticals LP v. Teva Pharmaceuticals USA Inc. (D. Del. 2014)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

AstraZeneca Pharmaceuticals LP v. Teva Pharmaceuticals USA Inc. (D. Del. 2014)

Docket   Start Trial Date Filed 2014-12-12
Court District Court, D. Delaware Date Terminated 2016-06-27
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Parties AMYLIN PHARMACEUTICALS LLC; ASTRAZENECA AB; ASTRAZENECA PHARMACEUTICALS LP; TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA INC.
Patents 5,424,286; 6,858,576; 6,872,700; 6,902,744; 6,956,026; 7,297,761; 7,521,423; 7,741,269
Attorneys Brianne Bharkhda; Daniel M. Silver; Einar Stole; Elaine H. Blais; Frederick H. Rein; Ira J. Levy; John W. Shaw; Joshua A. Whitehill; Karen Elizabeth Keller; Kathryn Garcin; Kaveh Saba; Michael P. Kelly; Molly R. Grammel; Reddy K. Srikanth
Link to Docket External link to docket
Small Molecule Drugs cited in AstraZeneca Pharmaceuticals LP v. Teva Pharmaceuticals USA Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for AstraZeneca Pharmaceuticals LP v. Teva Pharmaceuticals USA Inc. (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-12-12 1 Complaint 700, ’026, ’761, ’744, ’423, ’269 patents and U.S. Patent No. 5,424,286 are listed in the Approved Drug…of the patents listed in the Orange Book for NDA No. 021773, except U. S. Patent No. 5,424,286, which…of the ’576 patent, the ’700 patent, the ’026 patent, the ’744 patent, and the ’423 patent (collectively…expiration of U.S. Patent Nos. 6,858,576 (the “’576 patent”), 6,872,700 (the “’700 patent”), 6,956,026 (the…(the “’026 patent”), 7,297,761 (the “’761 patent”), 6,902,744 (the “’744 patent”), 7,521,423 (the “’423 External link to document
2015-02-09 16 Answer to Counterclaim United States Patent No. 6,858,576 19. Plaintiffs repeat and… United States Patent No. 6,858,576 39. Plaintiffs repeat and…744 patent and at times to the ’423 patent. To the extent paragraph 57 refers to the ’744 patent, Plaintiffs…744 patent and at times to the ’423 patent. To the extent paragraph 58 refers to the ’744 patent, Plaintiffs…the ’576, ’700, ’026, ’744 and ’423 patents and two other patents. Plaintiffs further admit that Teva External link to document
2014-12-12 4 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,858,576; 6,872,700; 6,956,026…2014 27 June 2016 1:14-cv-01478 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Medtronic
McKesson
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.